iSpecimen Enhances Global Oncology Biospecimen Offering: A Breakthrough in Precision Medicine
iSpecimen Strengthens Global Oncology Biospecimen Offering LEXINGTON, Mass., Dec. 07, 2023 (GLOBE NEWSWIRE) – iSpecimen Inc. (Nasdaq: ISPC) iSpecimen Adds New Suppliers and Expands Existing Relationships to Provide Researchers Increased Access to Highly-Sought-After Biospecimens to Advance Oncology Research iSpecimen Inc. has recently announced that they are enhancing their global oncology biospecimen offering by adding new…